XML 35 R24.htm IDEA: XBRL DOCUMENT
v3.21.2

Summary of Significant Accounting Policies (Details Narrative) - USD ($) | 3 Months Ended | 6 Months Ended |
--- | --- | --- | ---
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020
Product Information [Line Items] |  |  |  |  |
Cash FDIC insurance | $ 250,000 |  | $ 250,000 |  |
Cash SIPC insurance | 500,000 |  | 500,000 |  |
Patent and licensing costs | 108,193 | $ 143,444 | 228,352 | $ 276,912 |
Unrecognized tax benefits | $ 0 |  | $ 0 |  | $ 0
Deferred setup and organization costs, amortization period |  |  | 12 months |  |
Cost of Sales [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration of risk, percentage |  |  | 10.00% | 10.00% |
General and Administrative Expense [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration of risk, percentage | 7.50% | 56.30% | 8.40% | 50.70% |
Research and Development Expense [Member] | Revenue Benchmark [Member] | One Vendors and Consultants [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration of risk, percentage | 26.30% | 36.80% | 43.80% | 28.30% |
Research and Development Expense [Member] | Revenue Benchmark [Member] | Two Vendors and Consultants [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration of risk, percentage | 26.00% | 25.60% | 19.70% | 20.40% |
Research and Development Expense [Member] | Revenue Benchmark [Member] | Three Vendors and Consultants [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration of risk, percentage | 11.40% | 10.50% |  | 15.10% |
Research and Development Expense [Member] | Revenue Benchmark [Member] | Four Vendors And Consultants [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration of risk, percentage |  |  |  | 11.90% |

X
- Definition Cash SIPC insured amount. + References No definition available. + Details
Name: | LIXT_CashSIPCInsuredAmount
Namespace Prefix: | LIXT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amortization period for recovery of the deferred set-up and organization costs for Federal tax purposes. + References No definition available. + Details
Name: | LIXT_DeferredSetupAndOrganizationCostsAmortizationPeriod
Namespace Prefix: | LIXT_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Patent and licensing costs. + References No definition available. + Details
Name: | LIXT_PatentAndLicensingCosts
Namespace Prefix: | LIXT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. + References No definition available. + Details
Name: | us-gaap_CashFDICInsuredAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ProductInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of unrecognized tax benefits. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 10B -URI http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15A -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319 + Details
Name: | us-gaap_UnrecognizedTaxBenefits
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=LIXT_OneVendorsAndConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=LIXT_TwoVendorsAndConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=LIXT_ThreeVendorsAndConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=LIXT_FourVendorsAndConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |